Claims
- 1. A method for treating a patient suffering from muscular dystrophy, said method comprising the step of administering to said patient umbilical cord blood (UCB) cells.
- 2. The method of claim 1, wherein said UCB cells are injected into the blood stream of said patient.
- 3. The method of claim 1, wherein said UCB cells are injected into the muscle of said patient.
- 4. The method of claim 1, wherein prior to administration, the UCB cells are treated to increase their number and to render the cells enriched in relatively undifferentiated cells.
- 5. A cell transplant method for treating a patient suffering from muscular dystrophy while reducing rejection of said cells, said method comprising the steps of:
a) providing a preparation of UCB cells; b) reconstituting the immune system of said patient using cells of said preparation; and c) administering cells of said preparation to treat the patient's muscular dystrophy.
- 6. The method of claim 5, further comprising expanding cells of said preparation in vitro and repeatedly administering said expanded cells of said preparation to said patient to treat the patient's muscular dystrophy.
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of the filing date of U.S. provisional patent application No. 60/307,227, filed Jul. 23, 2001.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60307227 |
Jul 2001 |
US |